Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Show more
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company”...
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or...
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.7056 | 70.5035971223 | 1.0008 | 1.77 | 0.91 | 192263 | 1.36512504 | CS |
4 | 0.1364 | 8.68789808917 | 1.57 | 1.77 | 0.8001 | 57949 | 1.30755336 | CS |
12 | -0.1436 | -7.76216216216 | 1.85 | 2 | 0.8001 | 22841 | 1.36515759 | CS |
26 | -0.9936 | -36.8 | 2.7 | 3.08 | 0.8001 | 14265 | 1.59978886 | CS |
52 | -0.6636 | -28 | 2.37 | 3.3 | 0.8001 | 10329 | 1.90882647 | CS |
156 | -4.4336 | -72.2084690554 | 6.14 | 7.885 | 0.8001 | 9790 | 2.86292449 | CS |
260 | -5.6736 | -76.8780487805 | 7.38 | 9.33 | 0.8001 | 10897 | 4.00214154 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales